FHL1 and cancer: Interestingly, several studies have reported marked downregulation of FHL1 in various cancer types, including lung, prostate, breast, ovarian, colon, thyroid, brain, renal, oral, liver, and gastric cancer31–36, supported by microarray profiling and immunohistochemical analysis of human patient tissues.